A linear relationship has been found to exist between FVIII or FIX levels in people with hemophilia and thrombin generation parameters, showing that TGAs could be used to determine in vitro the patient-specific FVIII or FIX level to be reached to effectively normalize their thrombin generation and in turn reduce their bleeding tendency [42]. This evidence concerns the gene F8 and hemophilia.